fda warning letters glp-1 compounding october 2025 Compounded GLP-1s: Why doctors worry and the is cracking down CDER Warning Letters Jump 50%

Most users experience noticeable changes in body weight, however, while its short-term effectiveness is well-documented, concerns around long-term safety remain

Proper titration, which requires accurate reconstitution, helps manage these by allowing gradual dose escalation rather than sudden jumps

The complete longevity panel framework is in the Complete Guide to Genetic Longevity Testing

If you want to explore the broader wellness category tied to this discussion, visit our Immunity collection

For 5 mg/mL, add 12 mL

If youre following the July 2026 FDA Pharmacy Compounding Advisory Committee (PCAC) meeting on peptides like BPC-157 or MOTS-c, the GLP-1 import alert is a reminder of the bigger enforcement toolkit